UNSPSC 51343112: Navuridine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H11N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PS28W65479. The term NAVURIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. ). Most nations schedule navuridine under HS 29349990 and SITC 51579. As of Q4 2014, NAVURIDINE remains the US FDA Preferred Term for this commodity. Navuridine bears US NLM identifiers UMLS ID C0046786 and NCI Concept Code C83920.

SMILES: C1C(C(OC1N2C=CC(=O)NC2=O)CO)N=[N+]=[N-].

UNSPSC 51343112 Navuridine is a Commodity code that in recent state and local procurement appears to span pharmaceuticals and medical supplies more broadly than the code name alone suggests. Recent opportunities solicited under this code include naloxone procurement, direct-to-manufacturer pharmacy initiatives, emergency medical supplies for fire departments, and generic pharmaceutical products through cooperative purchasing vehicles. The issuing bodies are diverse: a Florida county health department, a state health and human services commission, a city fire department, and a multistate cooperative purchasing alliance. Scope of work centers on acquiring pharmaceutical products, medical consumables, and emergency supplies for public health and emergency response use, with vendors expected to manage logistics, comply with FDA and manufacturing standards, and often work through established wholesaler networks or direct contracting arrangements.

Activity spans Florida, Texas, and Minnesota with multistate reach through cooperative purchasing. Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries and a response deadline of July 26, 2023 (note: the response deadline in the source predates the posting date and may reflect a data error). The Texas Health and Human Services Commission issued a Request for Information in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The City of Tampa's Purchasing Department posted an ITB in March 2026 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000 and the opportunity designated as sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP due March 26, 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across state and local facilities in Minnesota and Oregon, requiring vendors to work through three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act certification.